Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Positron Corporation is a nuclear medicine healthcare company that specializes in the development, manufacturing, and marketing of Positron Emission Tomography (PET) imaging systems. The company primarily targets the cardiovascular and oncology markets, providing advanced diagnostic tools such as the Attrius PET and NeuSight PET/CT scanners. Positron's business model includes the sale of imaging hardware, clinical and technical support services, and financing solutions for healthcare providers. By focusing on high-resolution cardiac PET imaging, the company aims to improve the diagnosis and management of heart disease and other critical conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Positron Fiber Systems.